Ms. Hindler has worked as a clinical microbiologist for over 5 decades, mostly at UCLA Health System, Los Angeles, CA and currently at the Los Angeles County Department of Public Health. She is a fellow in the American Academy of Microbiology and long-standing volunteer with the CLSI Subcommittee on Antimicrobial Susceptibility Testing (AST). She has authored or co-authored numerous publications and book chapters and has received many awards for her contributions to AST and clinical microbiology.

Dr. Bobenchik is a board-certified clinical microbiologist with over 20 years of experience working in the laboratory. She is currently the Medical Director of Microbiology and Virology at Penn State Hershey Medical Center and Associate Professor of Pathology at Penn State College of Medicine. She has been a volunteer with CLSI since 2013 and is the current co-chair of the text and table working group and a member of the outreach working group.

Romney Humphries, PhD D(ABMM) is a Professor in the Department of Pathology, Microbiology and Immunology at Vanderbilt University Medical Center, where she is the Director of Infectious Diseases Laboratories and the Director of the Division of Laboratory Medicine. Romney received her PhD in bacteriology from the University of Calgary, Canada and a clinical and public health microbiology CPEP fellowship at UCLA.

Dr. Humphries is passionate about clinical microbiology and antimicrobial resistance in particular. She is a champion for the development of novel diagnostic tests for infectious diseases to transform how patients with infections are managed.

Lucia Berte tiene experiencia de varios años como formadora y consultora en gestión de la calidad en el laboratorio. Es autora de muchos artículos, capítulos y libros, y ha organizado conferencias virtuales, talleres y cursos de aprendizaje sobre la gestión de la calidad en laboratorios médicos para distintas entidades de laboratorio profesionales. Hizo parte del equipo de elaboración de las últimas dos ediciones de la Norma ISO 15189 de laboratorios clínicos y ha desarrollado directrices, materiales educativos y programas de aprendizaje en línea sobre sistemas de gestión de la calidad en el laboratorio para el CLSI.

Lucia Berte has many years’ experience as a trainer and consultant in laboratory quality management. She has authored many articles, chapters, and books and provided webconferences, workshops, and learning courses about medical laboratory quality management for several laboratory professional organizations. She served on the drafting team for the last two editions of the ISO 15189 medical laboratory standard and has developed guidelines, educational materials, and online learning programs about laboratory quality management systems for CLSI.

Dr. Bobenchik is a board-certified clinical microbiologist with over 20 years of experience working in the laboratory. She is currently the Medical Director of Microbiology and Virology at Penn State Hershey Medical Center and Associate Professor of Pathology at Penn State College of Medicine. She has been a volunteer with CLSI since 2013 and is the current co-chair of the text and table working group and a member of the outreach working group.

Kelli Maddock is the Section Head of the Microbiology and Biosafety Level-3 laboratories at the NDSU Veterinary Diagnostic Laboratory. She holds BS and MS degrees in Medical Laboratory Science and has work experience in human and veterinary laboratory medicine spanning 14 years. Kelli is also Doctor of Public Health (DrPH) candidate in the Clinical Laboratory Science and Practice concentration through the University of South Florida.

Paula Vagnone, MT (ASCP) is the Microbiology Unit Supervisor in the Infectious Disease Laboratory (IDL) of the Minnesota Department of Health (MDH), overseeing the general microbiology, mycobacterial, fungal, and antibiotic/antifungal testing areas of the laboratory. She serves as the Laboratory Coordinator of the Antibiotic Resistance Laboratory Network Central Region, a liaison-type role between the MDH Central Region Lab, the eight state public health laboratories and the epidemiology health care–associated infection coordinators in the region. 

Allison Brown, PhD, MPH, is the Associate Director of the Office of Laboratory Strategies and Analytics (OLSA) in the Division of Healthcare Quality Promotion at CDC. Dr. Brown’s team leads CDC’s Antibiotic Resistance Laboratory Network activities focused on detection and characterization of novel resistance in healthcare-associated infections. 

Romney Humphries, PhD D(ABMM) is a Professor in the Department of Pathology, Microbiology and Immunology at Vanderbilt University Medical Center, where she is the Director of Infectious Diseases Laboratories and the Director of the Division of Laboratory Medicine. Romney received her PhD in bacteriology from the University of Calgary, Canada and a clinical and public health microbiology CPEP fellowship at UCLA.

Dr. Humphries is passionate about clinical microbiology and antimicrobial resistance in particular. She is a champion for the development of novel diagnostic tests for infectious diseases to transform how patients with infections are managed.

Dr. Abbott is the Director of the Microbiology and Molecular Diagnostics Laboratory for Deaconess Health System, a large, multi-hospital network in Indiana, Kentucky, and Illinois. She is an American Board of Medical Microbiology diplomate and adjunct Assistant Professor at Indiana University School of Medicine and is on the Journal of Clinical Microbiology Editorial Board and serves on local and regional microbiology committees.

Dr. Abbott is a member of the Clinical Laboratory Standards Institute (CLSI) Antimicrobial Susceptibility Testing (AST) Subcommittee, including the Outreach Working Group. Her main area of interest is in antimicrobial susceptibility testing and resistance. She has a number of publications, book chapters, and presentations related to susceptibility testing, antimicrobial resistance, antimicrobial stewardship and diagnostic stewardship.

Felicia Rice, MT (ASCP) is currently the Technical Specialist II in the Microbiology Laboratory and an Instructor in Laboratory Medicine and Pathology at Mayo Clinic Hospital in Phoenix, Arizona. She is a member of the Text and Tables Working Group and is the Secretary for the Outreach Working Group.

Tsigereda Tekle MT (ASCP) graduated from Washington University with a BS in Medical Technology, and has worked in the Johns Hopkins Hospital Microbiology Department, where she is a Lead Medical Technologist of Antimicrobial Susceptibility Testing, for over 20 years. She is a CLSI member and serves on CLSI’s M45 Working Group. Ms. Tekle has also contributed her expertise to many posters and publications throughout the years. 

Diana L. Kremitske has 37 years’ experience in the laboratory profession with most of those years spent in hospitals of an integrated health system. Currently, Ms. Kremitske holds an executive leadership role as Vice President in the Diagnostic Medicine Institute at Geisinger - overseeing laboratory operations, and system courier services at eight hospital campuses and numerous clinics. She also participates in overseeing Geisinger’s Patient Blood Management Program. She received her bachelor’s degree in Medical Technology and a master’s degree in Chemistry and a master’s degree in Health Care Administration all from the University of Scranton, Scranton, Pa.

In addition to her laboratory career at Geisinger, Ms. Kremitske has coordinated a large scale, regional implementation project for an electronic medical record in physician practices at Geisinger and assisted in designing, as well as supporting best practice initiatives systemwide in the organization’s primary care network. She also has experience in the realm of laboratory quality, with part of her career as Laboratory Service Improvement Coordinator and contributor to the early development of a laboratory error reporting mechanism and database. She has also directed laboratory integration activities and process standardization efforts in hospital laboratory acquisitions and is involved in appropriate test utilization efforts.

Ms. Kremitske is a member of the ASCP and has been an active volunteer for the society since 2009, which includes being Chair of the Council of Laboratory Professionals in 2014-2015, and her current role as Chair of the Commission on Membership and Treasurer of the ASCP.

Ms. Kremitske is also a member of the American College of Health Care Executives and the American Society for Clinical Laboratory Science.

Barbara Booth, BS, MT (ASCP) CPHQ is the Laboratory Quality Systems Senior Coordinator at Geisinger Wyoming Valley Medical Center Wilkes Barre, Pennsylvania. She provides leadership in regulatory and quality management activities for the Geisinger Laboratory Medicine.  Barbara earned a BS degree in Medical Technology from Bloomsburg University of Pennsylvania, is certified in Just Culture and is a volunteer inspector for the College of American Pathologists.

Jeana Houseman, MHSA, DLM(ASCP)^CM is the Director of Quality, Patient Safety and Accreditation for Laboratories at HealthPartners, a large integrated health system based in Minnesota. In this role, she provides leadership and oversight for laboratory safety, quality improvement, education, data analytics, document control, regulatory and accreditation. Jeana has 18 years of healthcare experience, including roles in clinical microbiology, infection prevention and hospital regulatory compliance. She has previously spoken at regional and national conferences on the topics of microbiology testing, diagnostic stewardship, and high reliability in the lab. Her current areas of interest are regulatory compliance, high reliability, and test utilization.

Jessica Tredway is CLSI's Customer Relationship Manager. Her responsibilities include building, retaining, maintaining, and fostering relationships between CLSI and its stakeholders, including members, customers, volunteers and vendors.

Dr. Funke received her PhD from the University of Würzburg, Germany and trained as a postdoctoral fellow at the Albert Einstein College of Medicine where she identified the gene for 22q11 deletion syndrome.  She is Board certified in Clinical Molecular Genetics, served as Associate Professor of Pathology at Harvard Medical School where she was among the first worldwide to implement clinical NGS in 2011 at the Laboratory for Molecular Medicine in Cambridge. From 2017 to 2023, Dr. Funke has served in several leadership roles in commercial genetic testing laboratories where she focused on implementing and scaling testing for hereditary cancer, cardiovascular disease as well as proactive genomic applications.

Academically, Dr. Funke is known for her work on the genetic landscape of inherited cardiomyopathies, leading international efforts to develop professional guidelines for clinical genomic knowledge curation, as well as development of cutting edge clinical genomic tests. Her long-term goal is to help increase the use of genomic testing in clinical care, especially for disease prevention.

Barbara A. Brown-Elliott MS, MT(ASCP), SM is currently a Professor of Microbiology and Associate Director of the Mycobacteria/Nocardia Laboratory at the University of Texas Health Science Center at Tyler (UTHSCT). She has supervised the UTHSCT laboratory since 1988. Before coming to the UTHSCT, she served as a clinical microbiology supervisor, a consultant for a clinical microbiology reference laboratory, and a microbiology Adjunct Professor in medical technology. She is the author and/or co-author of more than 300 peer-reviewed articles and chapters on nontuberculous mycobacteria (NTM), Nocardia and other aerobic actinomycetes, with over 100 publications on antimicrobial susceptibility testing and resistance mechanisms. She has been a member of the American Society for Microbiology (ASM) since 1978 and is a frequent speaker at local, national, and international meetings. She is a member of the Clinical and Laboratory Standards Institute (CLSI) Antimycobacterial Susceptibility Subcommittee (Currently revised as the Antimycobacterial Susceptibility Working Group). She is a 2009 recipient of the Becton Dickinson Gardner Middlebrook Award for Outstanding Work in Mycobacteriology, the ASM Scherago-Rubin Award for outstanding clinical microbiologist in 2013, and an ASM Distinguished Lecturer from 2019-2020. 

Dr. Marie-Claire Rowlinson received her undergraduate and doctoral degrees in Medical Microbiology in the UK and then completed a post-doctoral fellowship in Medical and Public Health Laboratory Microbiology at University of California, Los Angeles. Following the fellowship, Dr. Rowlinson worked with the Association of Public Health Laboratories (APHL) in their Global Health program, building laboratory capacity in Eastern Europe, Africa, and the Caribbean. From 2012 to 2021, she held the position of Assistant Laboratory Director and CLIA Laboratory Director at the Florida Department of Health, Bureau of Public Health Laboratories in Jacksonville. Since September 2021, Dr. Rowlinson is the Chief of Bacterial Diseases at the Wadsworth Center, New York State Department of Health. Dr. Rowlinson’s expertise is in infectious disease diagnostics, in particular molecular diagnostics, tuberculosis, and global health. She continues to work closely with the Association of Public Health Laboratories and is the Chair of the APHL Infectious Diseases Committee and a Member of the TB Subcommittee. She also continues to work with APHL on an international level, consulting with the Global Health program, most recently working with the Ukraine Ministry of Health. Dr. Rowlinson is a Member of the College of American Pathologists Microbiology Committee.

Romney Humphries, PhD D(ABMM) is a Professor in the Department of Pathology, Microbiology and Immunology at Vanderbilt University Medical Center, where she is the Director of Infectious Diseases Laboratories and the Director of the Division of Laboratory Medicine.

Romney received her PhD in bacteriology from the University of Calgary, Canada and a clinical and public health microbiology CPEP fellowship at UCLA.

She worked at UCLA as an assistant professor in Pathology and laboratory medicine from 2010–2017 and was the section chief for clinical microbiology from 2012–2017. She then took on the role of Chief Scientific Officer at Accelerate Diagnostics from 2017–2020 before returning to academia in 2020, at VUMC.

Dr. Humphries is passionate about clinical microbiology and antimicrobial resistance in particular. She is a champion for the development of novel diagnostic tests for infectious diseases to transform how patients with infections are managed.

Dr. Humphries is an editor for the Journal of Clinical Microbiology and Clinical Infectious Diseases. She is a member of the Clinical and Laboratory Standards Institute (CLSI) Antibiotic Susceptibility Testing (AST) Subcommittee, the College of American Pathologists (CAP) Microbiology Committee, the American Society for Microbiology (ASM) Professional Practices Committee, and vice-chair of the Infectious Diseases Society of America Diagnostics Committee.

She is the author of over 150 peer-reviewed articles, numerous book chapters, and has lectured globally on the topics of antimicrobial resistance and diagnostic microbiology. Dr. Humphries is the 2022 ASM awardee for Leadership and Research in Clinical Microbiology. She is a fellow of the American Academy of Microbiology, and the Infectious Diseases Society of America.

Romney Humphries, PhD D(ABMM) is a Professor in the Department of Pathology, Microbiology and Immunology at Vanderbilt University Medical Center, where she is the Director of Infectious Diseases Laboratories and the Director of the Division of Laboratory Medicine.

Romney received her PhD in bacteriology from the University of Calgary, Canada and a clinical and public health microbiology CPEP fellowship at UCLA.

She worked at UCLA as an assistant professor in Pathology and laboratory medicine from 2010–2017 and was the section chief for clinical microbiology from 2012–2017. She then took on the role of Chief Scientific Officer at Accelerate Diagnostics from 2017–2020 before returning to academia in 2020, at VUMC.

Dr. Humphries is passionate about clinical microbiology and antimicrobial resistance in particular. She is a champion for the development of novel diagnostic tests for infectious diseases to transform how patients with infections are managed.

Dr. Humphries is an editor for the Journal of Clinical Microbiology and Clinical Infectious Diseases. She is a member of the Clinical and Laboratory Standards Institute (CLSI) Antibiotic Susceptibility Testing (AST) Subcommittee, the College of American Pathologists (CAP) Microbiology Committee, the American Society for Microbiology (ASM) Professional Practices Committee, and vice-chair of the Infectious Diseases Society of America Diagnostics Committee.

She is the author of over 150 peer-reviewed articles, numerous book chapters, and has lectured globally on the topics of antimicrobial resistance and diagnostic microbiology. Dr. Humphries is the 2022 ASM awardee for Leadership and Research in Clinical Microbiology. She is a fellow of the American Academy of Microbiology, and the Infectious Diseases Society of America.

Dr. Bobenchik is a board-certified clinical microbiologist with over 20 years of experience working in the laboratory. She is currently the Medical Director of Microbiology and Virology at Penn State Hershey Medical Center and Associate Professor of Pathology at Penn State College of Medicine. She has been a volunteer with CLSI since 2013 and is the current co-chair of the text and table working group and a member of the outreach working group.

Ms. Hindler has worked as a clinical microbiologist for over 50 years, including 40 years at UCLA Health System. Currently, she works as a consultant for the Los Angeles County Department of Public Health.  Janet has been a volunteer with CLSI for nearly 3 decades.

Romney Humphries, PhD D(ABMM) is a Professor in the Department of Pathology, Microbiology and Immunology at Vanderbilt University Medical Center, where she is the Director of Infectious Diseases Laboratories and the Director of the Division of Laboratory Medicine.

Romney received her PhD in bacteriology from the University of Calgary, Canada and a clinical and public health microbiology CPEP fellowship at UCLA.

She worked at UCLA as an assistant professor in Pathology and laboratory medicine from 2010–2017 and was the section chief for clinical microbiology from 2012–2017. She then took on the role of Chief Scientific Officer at Accelerate Diagnostics from 2017–2020 before returning to academia in 2020, at VUMC.

Dr. Humphries is passionate about clinical microbiology and antimicrobial resistance in particular. She is a champion for the development of novel diagnostic tests for infectious diseases to transform how patients with infections are managed.

Dr. Humphries is an editor for the Journal of Clinical Microbiology and Clinical Infectious Diseases. She is a member of the Clinical and Laboratory Standards Institute (CLSI) Antibiotic Susceptibility Testing (AST) Subcommittee, the College of American Pathologists (CAP) Microbiology Committee, the American Society for Microbiology (ASM) Professional Practices Committee, and vice-chair of the Infectious Diseases Society of America Diagnostics Committee.

She is the author of over 150 peer-reviewed articles, numerous book chapters, and has lectured globally on the topics of antimicrobial resistance and diagnostic microbiology. Dr. Humphries is the 2022 ASM awardee for Leadership and Research in Clinical Microbiology. She is a fellow of the American Academy of Microbiology, and the Infectious Diseases Society of America.

Dr. Bobenchik is a board-certified clinical microbiologist with over 20 years of experience working in the laboratory. She is currently the Medical Director of Microbiology and Virology at Penn State Hershey Medical Center and Associate Professor of Pathology at Penn State College of Medicine. She has been a volunteer with CLSI since 2013 and is the current co-chair of the text and table working group and a member of the outreach working group.